Back to Ensign Peak Advisors, Inc Ensign Peak Advisors, Inc

PTGXPTGX
Showing 8 of 23 quarters

Position history for Ensign Peak Advisors, IncEnsign Peak Advisors, Inc's holdings in PROTAGONIST THERAPEUTICS INC

Ensign Peak Advisors, Inc holds 3,786 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $464,088 as of 2026-Q2. The position was decreased (-15.6% shares). PTGX represents 0.0% of Ensign Peak Advisors, Inc's portfolio.

Current Value

$464,088

Current Shares

3,786

Total Value Change

-$752,532

Total Shares Change

-23,250

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3,786
-15.6%
$464,0880.0%$122.58
0
2026-Q1
Unchanged
4,486
0.0%
$472,8240.0%$91.30
0
2025-Q4
Decreased
4,486
-59.2%
$391,8070.0%$87.26
0
2025-Q3
Decreased
10,986
-52.5%
$729,8000.0%$65.14
0
2025-Q2
Decreased
23,136
-14.4%
$1.3M0.0%$55.69
0
2025-Q1
Unchanged
27,036
0.0%
$1.3M0.0%$48.88
0
2024-Q4
Unchanged
27,036
0.0%
$1M0.0%$38.51
0
2024-Q3
Unchanged
27,036
0.0%
$1.2M0.0%$44.56
0

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used